Explore the words cloud of the MIRIADE project. It provides you a very rough idea of what is the project "MIRIADE" about.
The following table provides information about the project.
Coordinator |
STICHTING VUMC
Organization address contact info |
Coordinator Country | Netherlands [NL] |
Total cost | 4˙034˙564 € |
EC max contribution | 4˙034˙564 € (100%) |
Programme |
1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers) |
Code Call | H2020-MSCA-ITN-2019 |
Funding Scheme | MSCA-ITN-ETN |
Starting year | 2019 |
Duration (year-month-day) | from 2019-11-01 to 2023-10-31 |
Take a look of project's partnership.
# | ||||
---|---|---|---|---|
1 | STICHTING VUMC | NL (AMSTERDAM) | coordinator | 265˙619.00 |
2 | STICHTING VU | NL (AMSTERDAM) | participant | 1˙062˙479.00 |
3 | ADX NEUROSCIENCES | BE (Gent) | participant | 512˙640.00 |
4 | LGC LIMITED | UK (TEDDINGTON) | participant | 303˙172.00 |
5 | GOETEBORGS UNIVERSITET | SE (GOETEBORG) | participant | 281˙982.00 |
6 | KUNGLIGA TEKNISKA HOEGSKOLAN | SE (STOCKHOLM) | participant | 281˙982.00 |
7 | F. HOFFMANN-LA ROCHE AG | CH (BASEL) | participant | 281˙276.00 |
8 | CENTRE HOSPITALIER UNIVERSITAIRE MONTPELLIER | FR (MONTPELLIER) | participant | 274˙802.00 |
9 | UNIVERSITA DEGLI STUDI DI PERUGIA | IT (PERUGIA) | participant | 261˙499.00 |
10 | UNIVERSITE DU LUXEMBOURG | LU (ESCH-SUR-ALZETTE) | participant | 256˙320.00 |
11 | UNIVERSITAET ULM | DE (ULM) | participant | 252˙788.00 |
Dementia is currently diagnosed largely based on cognitive decline, while pathology starts years before symptom onset. To make progress in the development of effective drugs for dementia, there is an urgent need for biomarkers to enable precision health: for early and specific diagnosis and objective monitoring of disease progression.
With its multidisciplinary team of scientists from academia, industry, and patient organisations, MIRIADE aims to train a new generation of scientists able to optimise and accelerate development of novel biomarkers for dementia. MIRIADE will integrate biomarker discovery data from multiple platforms and develop a Dementia Disease Map to enhance biomarker identification (WP1). We will develop assays for prioritized biomarkers (WP2), and selected markers will be clinically validated (WP3). We will study pre-analytical stability and validate against regulatory requirements (WP4) and develop a roadmap for optimal biomarker development (WP5). MIRIADE will thus establish an innovative biomarker-focussed cross-sectoral research and training programme that will equip ESRs with a unique combination of skills in big data analysis, biomarker assay development, innovation management, and a thorough understanding of medical needs. This programme will provide a new task force of scientists that are optimally trained to the accelerate the biomarker development for dementias and able to progress effective biomarker tools to the clinic.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIRIADE" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "MIRIADE" are provided by the European Opendata Portal: CORDIS opendata.